Specifically, YAP1 was upregulated in GC types, including gastric intestinal adenocarcinoma, diffuse gastric adenocarcinoma and gastric mixed adenocarcinoma compared with the gastric mucosa (fold changes of 1.979 [P < 0.001], 1.650 [P < 0.001] and 2.089 [P < 0.01], respectively, Fig. 6a–d). The gene discussed is YAP1; the disease is gastric cancer.